NASDAQ · Medical - Devices

MXCT (MXCT) Stock

$1.18 +6.31% NASDAQ: MXCT Healthcare

Valuation

MetricValue
Price$1.18
Market Cap$126.40M
P/E Ratio-2.55
P/B Ratio0.67
P/S Ratio3.55
EPS (TTM)$-0.42
52-Week High$2.37
52-Week Low$0.64
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-26.32%
ROA-22.17%
ROCE-26.16%
Gross Margin-136.36%
Operating Margin-136.36%
Net Margin-1.21%
Debt/Equity0.10
Current Ratio8.43

Annual Financials (USD)

Metric20212022202320242025
Revenue$34.0M$44.0M$41.0M$39.0M$33.0M
Operating Profit$-18.0M$-27.0M$-48.0M$-51.0M$-45.0M
Net Profit$-19.0M$-24.0M$-38.0M$-41.0M$-45.0M
EPS$-0.22$-0.19$-0.37$-0.39$-0.42
Op Margin-53.7%-61.8%-117.0%-132.5%-137.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$284.0M$287.0M$268.0M$239.0M$203.0M
Total Liabilities$21.0M$33.0M$36.0M$33.0M$31.0M
Cash$48.0M$11.0M$47.0M$28.0M$20.0M
Borrowings$6.0M$16.0M$19.0M$18.0M$18.0M

Latest News

MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026 GlobeNewswire · Jul 15, 2026 VectorBuilder Partners With MaxCyte® to Advance Clinical-Grade Cell Engineering Business Wire · Jun 23, 2026 12 Health Care Stocks Moving In Wednesday's Intraday Session Benzinga · May 13, 2026 Here’s Why MaxCyte (MXCT) is Becoming a High-Conviction Bet for Investors Insider Monkey · May 13, 2026 Cisco, Alibaba And 3 Stocks To Watch Heading Into Wednesday Benzinga · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-15.0M$-22.0M$-28.0M$-34.0M
Investing Cash Flow$-199.0M$-43.0M$51.0M$5.0M$24.0M
Financing Cash Flow$4.0M$0$2.0M$0$0
Net Cash Flow$29.0M$-37.0M$35.0M$-19.0M$-8.0M
Free Cash Flow$-15.0M$-33.0M$-25.0M$-29.0M$-36.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-25.74%
Quick Ratio11.29
Interest Coverage—
Return 1Y-36.61%
Return 3Y-72.16%
Return 5Y—

Ownership

Insiders Held1.59%
Institutions Held68.16%
Institutions Float Held69.26%
Institutional HolderSharesReport Date
Blackrock Inc.8,798,4732026-03-31
Capricorn Fund Managers Ltd8,200,0002026-03-31
Vitruvian Partners, LLP5,043,3562026-03-31
Vanguard Capital Management LLC3,981,8162026-03-31
Morgan Stanley3,688,1312026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARMPArmata Pharmaceuticals, Inc. $4.64 -0.43% -0.60 $170.34M 0.00%
AVR $8.28 +0.00% -2.56 $304.61M 0.00%
CATX $3.00 +1.01% -2.59 $342.14M 0.00%
LNSR $5.25 -1.87% 6.53 $63.55M 0.00%
NNOX $1.06 +3.92% -1.56 $73.78M 0.00%

About MXCT

MXCT is led by CEO Maher Masoud, employs 114 people, headquartered in US, publicly traded since 2021.

MXCT stock trades at $1.18 with a market capitalization of $126.40M. The stock is valued at a price-to-earnings (P/E) ratio of -2.55, price-to-book of 0.67, price-to-sales of 3.55. Over the past 52 weeks the stock has ranged between $0.64 and $2.37, and currently trades 50.2% below its 52-week high.

On profitability, MXCT generates a return on equity (ROE) of -26.32%, return on capital employed of -26.16%, an operating margin of -136.36%, a net profit margin of -1.21%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides